President and Chief Executive Officer
|Non-Equity Incentive Plan||$420,875|
In 2017, Douglas Ingram earned a total compensation of $56,866,241 as President and Chief Executive Officer at Sarepta Therapeutics, Inc..
Ingram received $44,484,000 in option awards, which accounts for 78.23% of total compensation.
Ingram also received $420,875 in non-equity incentive plan, $337,500 in salary, $11,607,750 in stock awards and $16,116 in other compensation.